Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report report published on Monday. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

Aethlon Medical stock opened at $0.40 on Monday. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35. The company has a 50-day simple moving average of $0.40 and a 200-day simple moving average of $0.42. The firm has a market capitalization of $5.64 million, a P/E ratio of -0.14 and a beta of 1.74.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.